Tag: NKE

Blue Horseshoe Stocks: SPEX, Options Recaps & More

Spherix Corp. SPEX

After initially signaling our interest in SPEX on June 20th, we’ve seen quite a run out of the stock as its gone from a low of .9505, and streaked to new highs this week.

SPEX gained some good ground on Wednesday, and yesterday morning we urged readers to look out for a momentum continuation– that’s precisely what came to pass. From daily low of 2.83 the stock streaked to 4.75. That went down as an intraday push of 68% and a total increase since we’ve been tracking this play amounting to a whopping 400% in barely a week’s time.

Volume remained strong, with SPEX trading more than 40X the monthly average volume on the day. We’ll want to see it continue to build higher base levels of support and hopefully continue to push the upper envelope.

CHF Solutions, Inc. CHFS

Also tagged in yesterday’s premarket report was CHFS, and it too made a pretty good move on the day. Volume was just dribbling in over the course of the morning, but shortly after lunch hour, the stock sprung into action.

From a low of .70 it reached as high as 1.08, which represents a 54% intraday pop. Our observed increase has been extended this morning as well, with premarket trading carrying CHFS even higher. Given the fact that this move was catalyzed by an FDA approval notice, we wouldn’t be surprised at all to see this blossom into a multi-day runner.

Chicago Bridge & Iron Co. CBI – Options Update

On Wednesday morning, we highlight a range of contracts in the CBI chain that we were interested in tracking, the CBI Weekly $20-22 Calls. As happens more often than not when we set our sights on an options play, every single contract has been good for sizable gains since our alert.

$20 Calls – Range: .75-1.90 – Max Gain: 153%
$20.50 Calls – Range: .38-1.30 – Max Gain: 242%
$21 Calls – Range: .25-1.22 – Max Gain: 388%
$21.50 Calls – Range: .20-.80 – Max Gain: 300%
$22 Calls – Range: .11-.55 – Max Gain: 400%

____

Fresh Options Idea: Nike, inc. NKE 07/07 $55.50-57 Calls

Extended Watchlist:
PIXY, SKLN, DPW, FSC HAIN, ITKG. OMER

Blue Horseshoe Stocks: NKE Review & More

NIKE, Inc. NKE – Options Update

Yesterday we brought a grouping of NKE options ideas to the table following a post-market options beat the previous day.

Despite the slow market conditions that are to be expected of a week leading into the year-end holidays, we felt that NKE was set to provide some opportunities, and we weren’t disappointed.

Our targets for “daytrades and/or swing trades” were the NKE Weekly $52.50-54 Calls and it appears as if both notions will turn out to be correct, with the stock looking like it could post another strong session today. As for the daytrades that were possible yesterday, we saw the most notable moves out of three sets of contracts in our highlighted range:

$52.50 Calls – Range: .15-.38 – Max Gain: 153%
$53 Calls – Range: .07-.21 – Max Gain: 200%
$29 Calls – Range: .03-.09 – Max Gain: 200%

ERF Wireless, Inc. ERFB

We want to provide a quick update on ERFB this morning, which we highlighted in last Friday’s premarket repot.  The stock saw a subsequent low of .0013 following that alert, and as of yesterday it had pushed as high as .0079.

That worked out to a 508% intraweek move up, so we want to say congrats to anyone who took this subpenny popper for a ride on the heels of last week’s tag.

Potential Bottom-Plays

We found a pair of stocks this morning that are both trading near their relative bottoms, with strong indications of impending rebounds on both of the charts.

Imprimis Pharmaceuticals, Inc. IMMY
& Ideal Power, Inc. IPWR

In addition to a ripe-looking chart, IMMY has seen some insider buying of late. A recent Form-4 filing revealed a significant buy ($280K) from CEO Mark Baum, who, coincidentally enough, also serves on the board of IPWR. We’re going to keep both of these stocks on recovery watch in the days and weeks ahead.

Fresh Options Idea:  MU Weekly $22-23.50 Calls

Extended Watchlist:
INAP, TKAI, RGSE, ANY, HTBX, SYRX

Blue Horseshoe Stocks: CNAT Recap & More

Conatus Pharmaceuticals, Inc. CNAT

We were fairly confident that at least one of the pharma news plays we put forth in yesterday’s premarket report would turn out a promising session, and CNAT definitely rose to the occasion.

We highlighted it, of course, because of a big collaboration and licensing deal for one of the company’s drugs, which adds a quick $50M cash to the books almost immediately, and even more down the road.

After gapping up considerably in the premarket, the stock underwent a dip-and-rip scenario which carried it to a daily low of 4.27 before it pushed its way up to a high of 5.50. That marked a solid intraday upswing of 29% and came on four times the three-month average volume.

ACADIA Pharmaceuticals, Inc. ACAD

ACAD was the other play off of our pharma watchlist that provided us with significant opportunities, which were even bigger than the previously mentioned stock.

We offered an options idea, the ACAD Weekly $28-31 Calls, and all but a couple sets of contracts in that range produced respectable intraday moves.

$28 Calls – Range: .70-1.66 – Max Gain: 137%
$28.50 Calls – Range: .59-1.40 – Max Gain: 137%
$29 Calls – Range: .40-.80 – Max Gain: 100%
$29.50 Calls – Range: .30-.70 – Max Gain: 133%
$30 Calls – Range: .18-.50 – Max Gain: 178%

______

NIKE, Inc. NKE – Fresh Options Idea

NKE is coming off a post-market earnings beat yesterday, so we want to enter an idea into the logs for this situation.

We’re going to be monitoring the activity in the NKE Weekly $52.50-54 Calls for possible daytrades and/or swing trades into the end of the week.

Extended Watchlist:
LEOM, MMEG, INO, ESEA, SINO, DCIX, DRYS, HIMX(Bottom-Watch)